Page last updated: 2024-10-28

hypericin and EHS Tumor

hypericin has been researched along with EHS Tumor in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Hypericin, a potent necrosis avid agent, features a peculiar affinity for necrotic tissue."7.74Exploration of the mechanism underlying the tumor necrosis avidity of hypericin. ( De Witte, PA; Ni, Y; Van de Putte, M, 2008)
"Hypericin, a potent necrosis avid agent, features a peculiar affinity for necrotic tissue."3.74Exploration of the mechanism underlying the tumor necrosis avidity of hypericin. ( De Witte, PA; Ni, Y; Van de Putte, M, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, B1
Roskams, T1
de Witte, PA2
Van de Putte, M1
Ni, Y1

Other Studies

2 other studies available for hypericin and EHS Tumor

ArticleYear
Antivascular tumor eradication by hypericin-mediated photodynamic therapy.
    Photochemistry and photobiology, 2002, Volume: 76, Issue:5

    Topics: Animals; Anthracenes; Blood Vessels; Disease Models, Animal; Female; Laser Therapy; Mice; Mice, Inbr

2002
Exploration of the mechanism underlying the tumor necrosis avidity of hypericin.
    Oncology reports, 2008, Volume: 19, Issue:4

    Topics: Animals; Anthracenes; Carbocyanines; Female; Fibrosarcoma; Lipoproteins; Mice; Mice, Inbred C3H; Nec

2008